Stocktoria
Aurinia Pharmaceuticals Inc. AUPH
Aurinia Pharmaceuticals Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | 3,467,514 | $58.8M | 2.5% |
| BlackRock Finance, Inc. | 9,272,162 | $52.9M | 6.69% |
| RENAISSANCE TECHNOLOGIES LLC | 1,548,035 | $26.3M | 1.12% |
| D. E. Shaw & Co., Inc. | 1,408,456 | $23.9M | 1.02% |
| AQR CAPITAL MANAGEMENT LLC | 948,751 | $16.1M | 0.68% |
| CITADEL ADVISORS LLC | 465,185 | $7.9M | 0.34% |
| MILLENNIUM MANAGEMENT LLC | 244,302 | $4.1M | 0.18% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.